Hemophilia is a rare genetic disorder characterized by the inability of the blood to clot properly, leading to excessive bleeding and easy bruising. It is caused by a deficiency in one of the blood clotting proteins, typically factor VIII (hemophilia A) or factor IX (hemophilia B). Research in hemophilia focuses on developing new treatments and therapies to help manage the symptoms of the disorder, improve quality of life, and ultimately find a cure. This includes the development of recombinant clotting factors, gene therapy, and other innovative treatments to address the underlying cause of the disorder. Additionally, research also explores the impact of hemophilia on patients' quality of life, psychosocial well-being, and long-term outcomes.